FoxM1 Is a General Target for Proteasome Inhibitors

Uppoor G. Bhat, Marianna Halasi, Andrei L. Gartel · 2009

Read FoxM1 Is a General Target for Proteasome Inhibitors by Uppoor G. Bhat, Marianna Halasi, Andrei L. Gartel (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006593.txt.

Description

Uppoor Bhat, Marianna Halasi, and Andrei Gartel studied a cancer transcription factor and proteasome drugs in PLOS ONE in 2009. Proteasome inhibitors are currently in the clinic or in clinical trials. The mechanism of their anticancer activity is not completely understood. The oncogenic transcription factor FoxM1 drives cell division genes.

Their title reports that FoxM1 is a general target for proteasome inhibitors. Blocking the proteasome lowers FoxM1, which may explain much of the drugs' effect. A shared target across cancer types is valuable. It also suggests measuring FoxM1 to predict which patients respond.

Catalog record

CREATORUppoor G. Bhat, Marianna Halasi, Andrei L. Gartel
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006593

Browse the full library · About the Tower of Babel